Article Text

Download PDFPDF
CP-242 Bevacizumab in glioblastoma or anaplasic astrocytoma: effectiveness, safety and cost effectiveness analysis
  1. MDP Vicente Sanchez1,
  2. JM Cano Cano2,
  3. R Perez Serrano1,
  4. MT Franco Sereno1,
  5. MDM Alañon Pardo1,
  6. M Mallol Yañez1,
  7. IDLD Benet Giménez1,
  8. M Rodríguez Martínez1
  1. 1Hospital Universitario General Ciudad Real, Pharmacy, Ciudad Real, Spain
  2. 2Hospital Universitario General Ciudad Real, oncology, Ciudad Real, Spain


This abstract was published in error and withdrawn at the author’s request.

Statistics from

Request Permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.